Accelia Capital is a Montréal-based venture capital firm investing in early-stage innovative technology companies across Canada and the United States, with a broader North America mandate and an emphasis on women-owned or women-led businesses. It targets companies that have completed product or service development and achieved market validation, with sector signals including healthtech, women’s health and femtech, cybersecurity, developer tools, AI, biotechnology, medical devices, SaaS and deep tech. The firm highlights a $60 million mandate.